Section of Animal Resources

Research Outline

In vivo evaluation of the compounds isolated from microbial metabolites or synthesized in the laboratory.

Animal Evaluation System Outline

1. Toxicity and PK/PD studies

①Acute toxicity
  • Weight changes
  • External changes
  • Anatomy findings
    • Observation for 14 days
②Pharmacokinetic examination
  • Serum
  • Urine
  • Excrement

2. Antitumor studies

①Antitumor examination
Human transplantable tumor
  • Lung : LX-1, DMS-273
  • Pancreatic : Capan-1, PANC-1
  • Colon : DLD-1
  • Prostate : LNCaP, PC-3, DU-145
  • Breast : BSY-1
  • Melanoma : LOX
  • Others
DMS-273 : Small cell lung carcinoma
DMS-273 : Small cell lung carcinoma
view
Human pancreatic carcinoma
Human pancreatic carcinoma
view
Mouse transplantable tumor
  • Ehrlich carcinoma
  • IMC carcinoma
  • Sarcoma : S180
  • Fibro sarcoma : Meth-A
  • Leukemia : L1210, EL4
  • Colon cancer : Colon26
  • Melanoma : B16-F10, B16-BL6
  • Others
②Antiangiogenic examination
Fig.2
view
③Antimetastatic examination
Fig.3
view

3. Antibacteria study

Model of the systemic infection caused by Staphylococcus aureus Smith.

Fig.4
view

4. Antiarthritic study

To induce arthritis, type II collagen emulsified with complete Freund’s adjuvant (CFA) is inoculated into the mouse on days 0 and 21. Footpad volumes and joint changes in the limbs are measured.

The experiment is performed in accordance with the Guidelines for Animal Experiments in the MCRF.